MOLN Stock Summary and Trading Ideas (Molecular Partners Ag - American Depositary Shares | NASDAQ:MOLN)

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company is currently focusing on oncology through their robust pipeline of clinical and preclinical programs, with particular attention to MP0712, the key Radio-DARPin candidate targeting DLL3 now in a Phase 1/2a trial in the United States.

Molecular Partners Ag - American Depositary Shares trades on the NASDAQ stock market under the symbol MOLN.

As of November 11, 2026, MOLN stock price declined to $3.09 with 446 million shares trading.

MOLN has a market cap of $118.46 million. This is considered a Micro Cap stock.

In the last 3 years, MOLN traded as high as $12.70 and as low as $3.09.

MOLN has underperformed the market in the last year with a price return of -27.3% while the SPY ETF gained +12.6%. MOLN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -25.2% and -18.9%, respectively, while the SPY returned -1.5% and -1.3%, respectively.

MOLN support price is $3.04 and resistance is $3.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MOLN shares will trade within this expected range on the day.